These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metabolic Profile of Calcium Oxalate Stone Patients with Enteric Hyperoxaluria and Impact of Dietary Intervention. Siener R, Ernsten C, Welchowski T, Hesse A. Nutrients; 2024 Aug 13; 16(16):. PubMed ID: 39203825 [Abstract] [Full Text] [Related]
3. Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery. Oxalogenic substances in diet contribute to urinary oxalate. Hofmann AF, Laker MF, Dharmsathaphorn K, Sherr HP, Lorenzo D. Gastroenterology; 1983 Feb 13; 84(2):293-300. PubMed ID: 6848409 [Abstract] [Full Text] [Related]
6. The urinary response to an oral oxalate load in recurrent calcium stone formers. Krishnamurthy MS, Hruska KA, Chandhoke PS. J Urol; 2003 Jun 13; 169(6):2030-3. PubMed ID: 12771711 [Abstract] [Full Text] [Related]
9. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption. Lindsjö M. Scand J Urol Nephrol Suppl; 1989 Jun 13; 119():1-53. PubMed ID: 2669121 [Abstract] [Full Text] [Related]
10. [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Sikora P, von Unruh GE, Beck B, Feldkötter M, Zajaczkowska M, Hesse A, Hoppe B. Kidney Int; 2008 May 13; 73(10):1181-6. PubMed ID: 18337715 [Abstract] [Full Text] [Related]
11. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D. Nephrol Dial Transplant; 2011 Nov 13; 26(11):3609-15. PubMed ID: 21460356 [Abstract] [Full Text] [Related]
15. Urine oxalate biological variation in patients with primary hyperoxaluria. Clifford-Mobley O, Sjögren A, Lindner E, Rumsby G. Urolithiasis; 2016 Aug 13; 44(4):333-7. PubMed ID: 26857252 [Abstract] [Full Text] [Related]
16. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P. Nephrol Dial Transplant; 1998 Sep 13; 13(9):2241-7. PubMed ID: 9761503 [Abstract] [Full Text] [Related]
17. Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Knight J, Jiang J, Assimos DG, Holmes RP. Kidney Int; 2006 Dec 13; 70(11):1929-34. PubMed ID: 17021603 [Abstract] [Full Text] [Related]
18. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria. Klimesova K, Whittamore JM, Hatch M. Urolithiasis; 2015 Apr 13; 43(2):107-17. PubMed ID: 25269440 [Abstract] [Full Text] [Related]
19. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Siener R, Ebert D, Nicolay C, Hesse A. Kidney Int; 2003 Mar 13; 63(3):1037-43. PubMed ID: 12631085 [Abstract] [Full Text] [Related]
20. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease. Perinpam M, Enders FT, Mara KC, Vaughan LE, Mehta RA, Voskoboev N, Milliner DS, Lieske JC. Clin Biochem; 2017 Dec 13; 50(18):1014-1019. PubMed ID: 28764885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]